Skip to main content
Cardiovascular Research logoLink to Cardiovascular Research
. 2020 Aug 9;116(13):2054. doi: 10.1093/cvr/cvaa240

Corrigendum to: Functional vascular smooth muscle cells derived from human induced pluripotent stem cells via mesenchymal stem cell intermediates cells via mesenchymal stem cell intermediates

PMCID: PMC8463088  PMID: 32772074

[Cardiovasc Res 2012;96:391–400 https://doi.org/10.1093/cvr/cvs253]

The authors regret an error in Figure 2C of this manuscript.

Figure 2.

Figure 2

A gene expression profile of hiPSC as they undergo differentiation. (A and B) RT-PCR for pluripotency-associated genes and genes associated with mesendodermal, endodermal, or ectodermal lineages in (A) F-iPSC; (B) HF-iPSC. (C and D) RT-PCR for EMT-associated genes at the indicated stages of hiPSC differentiation. Please note brightness contrast correction was used to enhance visibility for the purposes of clarity.

During the preparation of the figure, the author used HF-iPSC Vimentin and GAPDH gel images as a template to ensure the images were the same size and proportionally placed.

In error, this template was not removed, resulting in both Fig. 2C and 2D GAPDH and Vimentin gel images being the same. Original blots were provided to verify this and have been added as a supplement. The authors apologise sincerely for this error and the figure has now been corrected.

This matter was investigated by the ESC Journals Family Ethics Committee, who endorsed this resolution.

This change does not affect the overall scientific message of the paper.


Articles from Cardiovascular Research are provided here courtesy of Oxford University Press

RESOURCES